Detection of human T-lymphotropic virus type I p40^tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis

References

• Bangham C R M, Kermode A G, Hall S E, Daenke S. The cytotoxic T‐lymphocyte response to HTLV.‐I: the main determinant of disease?. Semin Virol 1996; 7: 41–48
   Google Scholar
• Bobrow M N, Harris T D, Shaughnessy K J, Litt G J. Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. J Immunol Methods 1989; 125: 279–285
   PubMed Web of Science ®Google Scholar
• Furukawa Y, Osame M, Kubota R, Tara M, Yoshida M. Human T‐cell leukemia virus type‐1 (HTLV‐1) Tax is expressed at the same level in infected cells of HTLV‐1‐associated myelopathy or tropical spastic paraparesis patients as in asymptomatic carriers but at a lower level in adult T‐cell leukemia cells. Blood 1995; 85: 1865–1870
   PubMed Web of Science ®Google Scholar
• Ijichi S, Eiraku N, Osame M, Izumo S, Kubota R, Maruyama I, Matsumoto M, Sonoda S. In vitro modulation of lymphocyte proliferation by prednisolone and interferon‐alpha in patients with HTLV.‐I‐associated myelopathy (HAM). J Neuroimmunol 1989; 23: 175–178
   Google Scholar
• Jacobson S, Shida H, McFarlin D E, Fauci A S, Koenig S. Circulating CD8+cytotoxic T lymphocytes specific for HTLV.‐I pX in patients with HTLV.‐I associated neurological disease. Nature 1990; 348: 245–248
   PubMed Web of Science ®Google Scholar
• Jacobson S, McFarlin D E, Robinson S, Voskuhl R, Martin R, Brewah A, Newell A J, Koenig S. HTLV.‐I‐specific cytotoxic T lymphocytes in the cerebrospinal fluid of patients with HTLV.‐I‐associated neurological disease. Ann Neurol 1992; 32: 651–657
   Google Scholar
• Kamentsky L A, Kamentsky L D. Microscope‐based multiparameter laser scanning cytometer yielding data comparable to flow cytometry data. Cytometry 1991; 12: 381–387
   PubMedGoogle Scholar
• Kamihira S, Toriya K, Amagasaki T, Momita S, Ikeda S, Yamada Y, Tomonaga M, Ichimaru M, Kinoshita K, Sawada T. Antibodies against p40tax gene product of human T‐lymphotropic virus type‐I (HTLV.‐I) under various conditions of HTLVT infection. Jpn J Cancer Res 1989; 80: 1066–1071
   Google Scholar
• Kannagi M, Shida H, Igarashi H, Kuruma K, Murai H, Aono Y, Maruyama I, Osame M, Hattori T, Inoko H. Target epitope in the Tax protein of human T‐cell leukemia virus type I recognized by class I major histocompatibility complex‐restricted cytotoxic T cells. J Virol 1992; 66: 2928–2933
   PubMedGoogle Scholar
• Kannagi M, Harada S, Maruyama I, Inoko H, Igarashi H, Kuwashima G, Sato S, Morita M, Kidokoro M, Sugimoto M, Funahashi S, Osame M, Shida H. Predominant recognition of human T cell leukemia virus type I (HTLV.‐I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV.‐I‐infected cells. Int Immunol 1991; 3: 761–767
   PubMed Web of Science ®Google Scholar
• Lee B, Tanaka Y, Tozawa H. Monoclonal antibody defining tax protein of human T‐cell leukemia virus type‐I. Tohoku J Exp Med 1989; 157: 1–11
   Web of Science ®Google Scholar
• Minato S, Itoyama Y, Goto I, Yamamoto N. Expression of HTLV.‐I antigen in cultured peripheral blood mononuclear cells from patients with HTLV.‐I associated myelopathy. J Neurol Sci 1988; 87: 233–244
   Google Scholar
• Moritoyo T, Reinhart T A, Moritoyo H, Sao E, Izumo S, Osame M, Haase A T. Human T‐lymphotropic virus type I‐associated myelopathy and tax gene expression in CD4+ T lymphocytes. Ann Neurol 1996; 40: 84–90
   PubMedGoogle Scholar
• Nakagawa M, Izumo S, Ijichi S, Kubota H, Arimura K, Kawabata M, Osame M. HTLV.‐I‐associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J Neurovirol 1995; 1: 50–61
   PubMed Web of Science ®Google Scholar
• World Health Organization. Report of the scientific group of HTLV.‐I and associated diseases, Kagoshima, Japan, Dec. 1988: Virus diseases. Human T‐lymphotropic virus type I, HTLV.‐I. WHO Weekly Epidemiol Rec 1989; 49: 382–383
   Google Scholar